Article Information
History
- August 18, 2020.
Article Versions
- Version 1 (August 13, 2020 - 15:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Di Liu1,#,
- Qiuyue Tian1,#,
- Jie Zhang1,
- Haifeng Hou2,
- Wei Wang1,2,3,
- Qun Meng1 and
- Youxin Wang1,2,4,*
- 1Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, 100069, China
- 2School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an 271016, Shandong Province, China
- 3School of Medical and Health Sciences, Edith Cowan University, Perth 60127, Australia
- 4Inner Mongolia Comprehensive Center for Disease Control and Prevention, Hohhot, Inner Mongolia Autonomous Region, China
- ↵*Youxin Wang, PhD, Professor, School of Public Health, Capital Medical University, No.10 Xitoutiao, Youanmenwai Street, Fengtai District, Beijing, 100069, China, Tel: +8613581719105; wangy{at}ccmu.edu.cn
↵# These authors contributed equally to this study
Posted August 18, 2020.
Association of 25 hydroxyvitamin D concentration with risk of COVID-19: a Mendelian randomization study
